Spruce Biosciences, Inc.
SPRB
$0.0866
-$0.0432-33.28%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -136.77% | 29.81% | 28.41% | 9.12% | 10.71% |
| Total Depreciation and Amortization | -43.75% | -41.18% | -33.33% | -21.05% | -33.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -15.57% | 15.47% | 70.37% | 73.11% | 1,078.64% |
| Change in Net Operating Assets | 174.25% | -81.29% | -126.76% | -11,144.44% | -245.21% |
| Cash from Operations | -84.47% | 24.83% | -657.25% | -26.87% | 4.51% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -36.17% |
| Cash from Investing | -- | -- | -- | -- | -36.17% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | 0.00% | -- |
| Issuance of Common Stock | -80.28% | -- | -51.40% | -99.66% | 86.84% |
| Repurchase of Common Stock | -7.37% | -- | 84.51% | 91.30% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -13.22% | 0.00% | 15.51% | -100.45% | -1,633.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -765.58% | -829.95% | -148.69% | -130.85% | -185.84% |